31st Aug 2018 15:04
LONDON (Alliance News) - Creo Medical Group PLC said Friday that Chief Executive Officer Craig Gulliford and Chief Technology Officer Chris Hancock both sold 480,000 shares in the company.
Both Gulliford and Hancock sold their shares at a price of 125 pence per share, for a total of GBP600,000 each.
Gulliford now holds an interest in 609,886 shares, representing 0.5% of the company's total issued share capital, while Hancock holds an interest in 4.4 million shares, representing 3.7% stake.
Shares in Creo Medical were down 4.0% Friday at 158.00p each.
Related Shares:
Creo Medical